The entertainment world was rocked by the death of beloved comedian and actor Pat Finn back on December 22. He was just 60.

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead ...

With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

NEW YORK — Alpenglow Biosciences has partnered with digital pathology lab PathNet to develop 3D pathology-based diagnostics for prostate and bladder cancers, the companies said on Thursday.

The Middle and Friends actor Pat Finn’s cause of death has been released after he died on Dec. 22 at the age of 60. The ...

“The Middle” actor Pat Finn’s cause of death has been revealed, two weeks after he died at age 60. Finn passed away on Dec.